Jury awards $289M to man who blames Roundup for cancer - | WBTV Charlotte

Jury awards $289M to man who blames Roundup for cancer

(Josh Edelson/Pool Photo via AP, File). FILE - In this July, 9, 2018, file photo, plaintiff DeWayne Johnson looks up during a brief break as the Monsanto trial in San Francisco. Monsanto is being accused of hiding the dangers of its popular Roundup pro... (Josh Edelson/Pool Photo via AP, File). FILE - In this July, 9, 2018, file photo, plaintiff DeWayne Johnson looks up during a brief break as the Monsanto trial in San Francisco. Monsanto is being accused of hiding the dangers of its popular Roundup pro...
(AP Photo/Jeff Roberson, File). FILE - In this June 28, 2011, file photo, bottles of Roundup herbicide, a product of Monsanto, are displayed on a store shelf in St. Louis. A San Francisco jury on Friday, Aug. 10, 2018, ordered agribusiness giant Monsan... (AP Photo/Jeff Roberson, File). FILE - In this June 28, 2011, file photo, bottles of Roundup herbicide, a product of Monsanto, are displayed on a store shelf in St. Louis. A San Francisco jury on Friday, Aug. 10, 2018, ordered agribusiness giant Monsan...
(Josh Edelson/Pool Photo via AP). Plaintiff Dewayne Johnson reacts after hearing the verdict in his case against Monsanto at the Superior Court of California in San Francisco on Friday, Aug. 10, 2018. A San Francisco jury on Friday ordered agribusiness... (Josh Edelson/Pool Photo via AP). Plaintiff Dewayne Johnson reacts after hearing the verdict in his case against Monsanto at the Superior Court of California in San Francisco on Friday, Aug. 10, 2018. A San Francisco jury on Friday ordered agribusiness...
(Josh Edelson/Pool Photo via AP). Plaintiff Dewayne Johnson, facing camera, hugs one of his lawyers after hearing the verdict in his case against Monsanto at the Superior Court of California in San Francisco on Friday, Aug. 10, 2018. A San Francisco ju... (Josh Edelson/Pool Photo via AP). Plaintiff Dewayne Johnson, facing camera, hugs one of his lawyers after hearing the verdict in his case against Monsanto at the Superior Court of California in San Francisco on Friday, Aug. 10, 2018. A San Francisco ju...
(AP Photo/Paul Elias). Plaintiff Dewayne Johnson, center at podium, surrounded by his attorneys, takes questions from the media after the Monsanto trial in San Francisco Friday, Aug. 10, 2018. A San Francisco jury ordered agribusiness giant Monsanto to... (AP Photo/Paul Elias). Plaintiff Dewayne Johnson, center at podium, surrounded by his attorneys, takes questions from the media after the Monsanto trial in San Francisco Friday, Aug. 10, 2018. A San Francisco jury ordered agribusiness giant Monsanto to...

By PAUL ELIAS
Associated Press

SAN FRANCISCO (AP) - A jury's $289 million award to a former school groundskeeper who said Monsanto's Roundup left him dying of cancer will bolster thousands of pending cases and open the door for countless people who blame their suffering on the weed killer, the man's lawyers said.

"I'm glad to be here to be able to help in a cause that's way bigger than me," Dewayne Johnson said at a news conference Friday after the verdict was announced.

Johnson, 46, alleges that heavy contact with the herbicide caused his non-Hodgkin's lymphoma. The state Superior Court jury agreed that Roundup contributed to Johnson's cancer and Monsanto should have provided a label warning of the potential health hazard.

Johnson thanked jurors "from the bottom of my heart" for their work, along with his lawyers and his family.

His was the first case filed by a cancer patient against the agribusiness giant to reach trial. It was expedited because court filings indicated that Johnson was dying. His victory may set the precedent for many others.

"A unanimous jury in San Francisco has told Monsanto: 'Enough. You did something wrong and now you have to pay,'" said Brent Wisner, Johnson's lead trial lawyer. "There's 4,000 other cases filed around the United States and there are countless thousand other people out there who are suffering from cancer because Monsanto didn't give them a choice ... We now have a way forward."

Monsanto has denied a link between the active ingredient in Roundup - glyphosate - and cancer, saying hundreds of studies have established that glyphosate is safe.

Monsanto spokesman Scott Partridge said the company will appeal. Partridge said scientific studies and two government agencies have concluded that Roundup does not cause cancer.

"We are sympathetic to Mr. Johnson and his family," Partridge said. "We will appeal this decision and continue to vigorously defend this product, which has a 40-year history of safe use and continues to be a vital, effective, and safe tool for farmers and others."

Johnson used Roundup and a similar product, Ranger Pro, as a pest control manager at a San Francisco Bay Area school district, his lawyers said. He sprayed large quantities from a 50-gallon tank attached to a truck, and during gusty winds, the product would cover his face, said Brent Wisner, one of his attorneys.

Once, when a hose broke, the weed killer soaked his entire body.

Johnson read the label and even contacted the company after developing a rash but was never warned it could cause cancer, Wisner said. He was diagnosed with non-Hodgkin's lymphoma in 2014.

"The simple fact is he is going to die. It's just a matter of time," Wisner told the jury in his opening statement last month.

But George Lombardi, an attorney for Monsanto, said non-Hodgkin's lymphoma takes years to develop, so Johnson's cancer must have started well before he began working at the school district.

The U.S. Environmental Protection Agency says Roundup's active ingredient is safe for people when used in accordance with label directions.

However, the France-based International Agency for Research on Cancer, which is part of the World Health Organization, classified it as a "probable human carcinogen" in 2015. California added glyphosate to its list of chemicals known to cause cancer.

Johnson's attorneys sought and won $39 million in compensatory damages and $250 million of the $373 million they wanted in punitive damages.

Copyright 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

  • Latest health & fitness newsLatest health & fitness newsMore>>

  • Synthetic pot seen as a public health danger

    Synthetic pot seen as a public health danger

    Friday, August 17 2018 12:35 PM EDT2018-08-17 16:35:48 GMT
    Saturday, August 18 2018 8:11 PM EDT2018-08-19 00:11:39 GMT
    (Brian A. Pounds/Hearst Connecticut Media via AP). FILE - In this Thursday, Aug. 16, 2018 file photo, paramedics and EMT members respond to one of three simultaneous drug overdose victims on the New Haven Green, a city park in New Haven, Conn. Police s...(Brian A. Pounds/Hearst Connecticut Media via AP). FILE - In this Thursday, Aug. 16, 2018 file photo, paramedics and EMT members respond to one of three simultaneous drug overdose victims on the New Haven Green, a city park in New Haven, Conn. Police s...
    What is synthetic marijuana and why is it so dangerous?.More >>
    What is synthetic marijuana and why is it so dangerous?.More >>
  • Multi-gene test may find risk for heart disease and more

    Multi-gene test may find risk for heart disease and more

    Monday, August 13 2018 2:24 PM EDT2018-08-13 18:24:18 GMT
    Saturday, August 18 2018 8:11 PM EDT2018-08-19 00:11:36 GMT
    New way to track millions of genetic variations promises better forecasting of people's risk for heart attacks, four other disorders.More >>
    New way to track millions of genetic variations promises better forecasting of people's risk for heart attacks, four other disorders.More >>
  • US approves new generic competitor to EpiPen

    US approves new generic competitor to EpiPen

    Thursday, August 16 2018 3:47 PM EDT2018-08-16 19:47:00 GMT
    Saturday, August 18 2018 8:11 PM EDT2018-08-19 00:11:34 GMT
    The new generic version will be sold by Teva Pharmaceuticals. (Source: AP Photo/Rich Pedroncelli, File)The new generic version will be sold by Teva Pharmaceuticals. (Source: AP Photo/Rich Pedroncelli, File)

    US officials approves new generic competitor for emergency allergy medication EpiPen.

    More >>

    US officials approves new generic competitor for emergency allergy medication EpiPen.

    More >>
Powered by Frankly